Vertex Pharmaceuticals Inc (VRTX) Stock Forecast
US · Healthcare
Current price
$480.18
Market cap
$121.87B
Mean price target
$548.69
Implied upside
14.3%
Key takeaways
- Analysts rate Vertex Pharmaceuticals Inc a “Buy”, with a mean price target of $548.69 — about 14.3% upside from the current $480.18, based on 29 analysts.
- VRTX is trading near its 52-week high, at 81% of the $362.50–$507.92 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 29 |
| Mean target | $548.69 |
| High target | $641.00 |
| Low target | $330.00 |
| Rating split (SB / B / H / S / SS) | 5 / 22 / 4 / 1 / 1 |
Price & trading
| Current price | $480.18 |
|---|---|
| Previous close | $475.12 |
| 52-week high | $507.92 |
| 52-week low | $362.50 |
| 50-day average | $439.81 |
| Beta | 0.31 |
See the full VRTX breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Vertex Pharmaceuticals Inc (VRTX) share price?
- Vertex Pharmaceuticals Inc last traded at $480.18 with a market capitalisation of about $121.9B.
- What is the analyst price target for VRTX?
- The mean analyst price target for Vertex Pharmaceuticals Inc is $548.69, roughly 14.3% above the latest price. The current consensus rating is “Buy”.
- Where can I see Vertex Pharmaceuticals Inc's full financial metrics?
- Luminoso tracks VRTX's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.